Bayer (BAYRY)
(Delayed Data from OTC)
$7.39 USD
+0.12 (1.65%)
Updated Apr 26, 2024 03:59 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BAYRY 7.39 +0.12(1.65%)
Will BAYRY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BAYRY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAYRY
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
BAYRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges
Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
Other News for BAYRY
Bayer goes ex dividend Monday
GLOBAL BRIEFING: Yen slumps to new multi-decade low as BoJ stands pat
Missouri House backs legal shield for weedkiller maker facing thousands of cancer-related lawsuits
IN BRIEF: Bayer secures licencing rights for new AlphaBio insecticide
IN BRIEF: Bayer signs renewable power supply deal for German sites